#1 Clinical Trials Search in Europe

Clomifene Citrate

Clomifene Citrate, also known as Clomid, is a medication commonly used in clinical trials for various fertility and hormonal conditions. This article explores the use of Clomifene Citrate in clinical studies, focusing on its applications in treating infertility, ovulatory dysfunction, and secondary hypogonadism. We’ll examine different administration methods, dosages, and compare its effectiveness to other treatments.

Table of Contents

What is Clomiphene Citrate?

Clomiphene Citrate, also known by its brand name Clomid, is a medication primarily used to treat infertility in both women and men[1]. It belongs to a class of drugs called selective estrogen receptor modulators (SERMs), which means it can interact with estrogen receptors in the body[2]. This medication has been widely studied and used in various clinical trials to address different reproductive health issues.

Medical Conditions Treated

Clomiphene Citrate is used to treat several medical conditions related to reproductive health:

  • Female Infertility: It is commonly used to induce ovulation in women who have difficulty ovulating naturally[1].
  • Polycystic Ovarian Syndrome (PCOS): This medication can help women with PCOS to ovulate regularly[3].
  • Ovulatory Dysfunction: It helps regulate the menstrual cycle in women with irregular periods[5].
  • Male Secondary Hypogonadism: In men, it can be used to treat low testosterone levels caused by problems with the pituitary gland[4].

How It Works

Clomiphene Citrate works by stimulating the release of hormones necessary for ovulation in women and testosterone production in men. Here’s how it functions in different scenarios:

  • In Women: It stimulates the release of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) from the pituitary gland. These hormones are crucial for the development and release of mature eggs from the ovaries[3].
  • In Men: It increases the production of testosterone by stimulating the pituitary gland to release more LH and FSH, which in turn stimulate the testes to produce more testosterone[4].

Administration Methods

Clomiphene Citrate is typically administered orally in tablet form. The dosage and duration of treatment can vary depending on the specific condition being treated and the individual patient’s response. Here are some common administration methods:

  • Traditional Administration: This involves taking Clomiphene Citrate for 5 days, usually starting on day 3, 4, or 5 of the menstrual cycle. If ovulation doesn’t occur, the dose may be increased in subsequent cycles[5].
  • Stair-Step Approach: This is a newer method where the dose is increased without waiting for the next menstrual cycle if ovulation doesn’t occur. This approach may reduce the time to ovulation and potentially pregnancy[5].
  • For Male Patients: In men with secondary hypogonadism, Clomiphene Citrate may be taken daily for several months to improve testosterone levels[4].

Side Effects and Safety

While Clomiphene Citrate is generally considered safe, it can cause some side effects. Common side effects may include:

  • Hot flashes
  • Mood swings
  • Breast tenderness
  • Nausea
  • Headaches
  • Visual disturbances (rare)

It’s important to note that Clomiphene Citrate can increase the chance of multiple pregnancies (twins, triplets, etc.). Regular monitoring by a healthcare provider is essential during treatment to ensure safety and effectiveness[3][5].

Alternative Formulations

While Clomiphene Citrate is the most commonly used form of this medication, there are alternative formulations being studied:

  • Enclomiphene Citrate: Also known by the brand name Androxal, this is a purified form of Clomiphene Citrate. It’s being studied for use in men with secondary hypogonadism and may have fewer side effects than traditional Clomiphene Citrate[6][7].

These alternative formulations are still under investigation and may not be widely available for general use. Always consult with your healthcare provider about the most appropriate treatment options for your specific condition.

Aspect Details
Primary Uses Treatment of infertility, ovulatory dysfunction, secondary hypogonadism
Administration Oral tablets, typically 50-100 mg daily for 5 days in women; daily doses in men
Common Side Effects Hot flashes, mood swings, breast tenderness, abdominal discomfort
Comparison Studies Compared with Letrozole for ovulation induction in PCOS
Novel Approaches Stair-step protocol for potentially faster ovulation induction
Male Infertility Used in non-obstructive azoospermia to potentially increase sperm production
Related Medications Enclomiphene Citrate (Androxal) for secondary hypogonadism in men

FAQ

  • What is Clomifene Citrate used for in clinical trials? Clomifene Citrate is primarily used in clinical trials for treating infertility, ovulatory dysfunction, and secondary hypogonadism. It's often used to induce ovulation in women and to increase testosterone levels in men.
  • How is Clomifene Citrate typically administered? Clomifene Citrate is usually taken orally in tablet form. The dosage and duration can vary, but common protocols include 50-100 mg daily for 5 days, starting on specific days of the menstrual cycle for women, or daily doses for men with hypogonadism.
  • What are some potential side effects of Clomifene Citrate? While side effects can vary, some common ones include hot flashes, mood swings, breast tenderness, and abdominal discomfort. In rare cases, it may cause visual disturbances or ovarian hyperstimulation syndrome.
  • How does Clomifene Citrate compare to other fertility treatments? Some trials compare Clomifene Citrate to other treatments like Letrozole. The effectiveness can vary depending on the specific condition being treated. For example, one study compared Letrozole to Clomifene Citrate for ovulation induction in women with polycystic ovarian syndrome.
  • Are there different approaches to administering Clomifene Citrate? Yes, some trials explore different administration methods. For instance, one study compared a traditional administration protocol to a 'stair-step' approach, which may reduce the time to ovulation by adjusting doses more quickly based on patient response.

Ongoing Clinical Trials on Clomifene Citrate

  • Study on the Effect of Ovarian Stimulation Intensity Using Clomifene Citrate and Follitropin Alfa in Women with Infertility and Suboptimal Response

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

Glossary

  • Clomifene Citrate: A medication used to treat infertility in women by stimulating ovulation. It's also known as Clomid or Clomiphene Citrate.
  • Secondary Hypogonadism: A condition where the testes or ovaries produce little or no sex hormones due to problems with the pituitary gland or hypothalamus.
  • Ovulation Induction: The process of using medications to stimulate the ovaries to produce and release eggs.
  • Polycystic Ovarian Syndrome (PCOS): A hormonal disorder common among women of reproductive age, often causing irregular menstrual periods and difficulty getting pregnant.
  • Azoospermia: A medical condition where a man's semen contains no sperm.
  • Intracytoplasmic Sperm Injection (ICSI): A fertility treatment where a single sperm is injected directly into an egg to facilitate fertilization.
  • Follicle Stimulating Hormone (FSH): A hormone that stimulates the growth of ovarian follicles in women and sperm production in men.
  • Luteinizing Hormone (LH): A hormone that triggers ovulation in women and stimulates testosterone production in men.
  • Stair-step Protocol: An approach to administering Clomifene Citrate where the dose is increased without waiting for a new menstrual cycle, potentially reducing time to ovulation.
  • Androxal: A brand name for Enclomiphene Citrate, a medication similar to Clomifene Citrate used to treat secondary hypogonadism in men.

References

  1. https://clinicaltrials.gov/study/NCT01791751
  2. https://clinicaltrials.gov/study/NCT03615547
  3. https://clinicaltrials.gov/study/NCT00478504
  4. https://clinicaltrials.gov/study/NCT01067365
  5. https://clinicaltrials.gov/study/NCT01008319
  6. https://clinicaltrials.gov/study/NCT01739582
  7. https://clinicaltrials.gov/study/NCT01984398